AR014000A1 - Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro - Google Patents

Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro

Info

Publication number
AR014000A1
AR014000A1 ARP980105483A ARP980105483A AR014000A1 AR 014000 A1 AR014000 A1 AR 014000A1 AR P980105483 A ARP980105483 A AR P980105483A AR P980105483 A ARP980105483 A AR P980105483A AR 014000 A1 AR014000 A1 AR 014000A1
Authority
AR
Argentina
Prior art keywords
alkyl
work
arylamine
cyclooxygenase
inhibitors
Prior art date
Application number
ARP980105483A
Other languages
English (en)
Spanish (es)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of AR014000A1 publication Critical patent/AR014000A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP980105483A 1997-10-31 1998-10-30 Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro AR014000A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6388997P 1997-10-31 1997-10-31

Publications (1)

Publication Number Publication Date
AR014000A1 true AR014000A1 (es) 2001-01-31

Family

ID=22052179

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105483A AR014000A1 (es) 1997-10-31 1998-10-30 Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro

Country Status (9)

Country Link
EP (1) EP1027048A2 (US06815460-20041109-C00023.png)
JP (1) JP2001521889A (US06815460-20041109-C00023.png)
AR (1) AR014000A1 (US06815460-20041109-C00023.png)
AU (1) AU758566B2 (US06815460-20041109-C00023.png)
BR (1) BR9813164A (US06815460-20041109-C00023.png)
CA (1) CA2308639A1 (US06815460-20041109-C00023.png)
TW (2) TW577739B (US06815460-20041109-C00023.png)
WO (1) WO1999022720A2 (US06815460-20041109-C00023.png)
ZA (1) ZA989876B (US06815460-20041109-C00023.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020188016A9 (en) * 2000-06-08 2002-12-12 Peterson Johnny W. Heterocycle derivatives and methods of use
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161789A1 (en) * 1993-05-13 1994-11-24 Jacques Yves Gauthier 2-substituted-3,4-diarylthiophene derivatives as inhibitors of cyclooxygenase
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
EP0889724A1 (en) * 1996-02-27 1999-01-13 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US5677318A (en) * 1996-07-11 1997-10-14 Merck Frosst Canada, Inc. Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents

Also Published As

Publication number Publication date
TW577739B (en) 2004-03-01
EP1027048A2 (en) 2000-08-16
JP2001521889A (ja) 2001-11-13
AU1192699A (en) 1999-05-24
ZA989876B (en) 1999-10-29
BR9813164A (pt) 2000-08-22
WO1999022720A3 (en) 1999-08-26
CA2308639A1 (en) 1999-05-14
TW200404535A (en) 2004-04-01
AU758566B2 (en) 2003-03-27
WO1999022720A2 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
CU23116A3 (es) Derivados de bencensulfonamida sustituida, como inhibidores de cox-2
NZ509755A (en) Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
PT772597E (pt) Pirazoles 3,4-substituidos para o tratamento de inflamacao
PL322419A1 (en) Novel substituted compounds of biphenyl or phenylopyridine, method of obtaining them as well as pharmaceutic compositions containing such compounds
MX2021015605A (es) Compuestos 2,3-dihidroquinazolin como inhibidores nav1.8.
BRPI0413848A (pt) composto, processo para preparar o composto, composição terapêutica para prevenir inflamação e apoptose, método para prevenir inflamação e apoptose, e, uso de composto inibidor de caspase, ou de seu sal, ou de seu estereoisÈmero
HU9503319D0 (en) Phenyl heterocycles as cyclooxygenase-2 inhibitors
PL356252A1 (en) Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
CY1107069T1 (el) Χρηση των αναστολεων της cox-2 σαν ανοσοδιεγερτες στη θεραπεια του hiv ή του aids
DK0715623T3 (da) Blodpladeaggregationsinhibitorer
AR014000A1 (es) Metodo para utilizar inhibidores de ciclooxigenasa-2 en el mantenimiento del ductus ateriosus fetal durante el tratamiento y la prevencion del trabajode parto prematuro
PT880504E (pt) Imidazoles substituidos por heterociclo para o tratamento de inflamacao
DK0659193T3 (da) Blodpladeaggregationsinhibitorer
CR20210143A (es) Utilización de un inhibidor de catepsina s contra la formación de anticuerpos anti-fármaco
HUP9901505A2 (hu) Dehidroepiandroszteron és aromatázgátlók kombinációja és e kombináció felhasználása férfiak relatív és abszolút androgénhiányának kezelésére szolgáló gyógyszerkészítmények előállítására
AR038199A1 (es) Terapia combinada para el tratamiento de infecciones bacterianas
BRPI0407039A (pt) Uso de uma combinação de um inibidor de aromatase, uma progestina e um estrogênio, composição farmacêutica, e, método do tratamento de endometriose
FR3077201B1 (fr) Derives aminoacides contenant un groupement disulfanyle sous forme d'un inhibiteur de nep et d'apn pour la prevention et le traitement des douleurs relatives au nerf trijumeau
PA8471901A1 (es) Derivados de 2"-desoxi higromicina
AR020306A1 (es) Composicion terapeutica y su uso como inhibidora de la ciclooxigenasa-2 en la prevencion de alteraciones cardiovasculares.
CL2008003412A1 (es) Uso de compuestos no beta-oxidables de formula r"-coo-(ch2)2n+1-x-r para preparar una composicion nutricional y/o farmaceutica par inhibir la maduracion sexual de peces.
KR950703575A (ko) 신규의 옥사 또는 아자스테로이드 7위치 치환 화합물 [novel 7-sunstituted oxa-or azasteroid compound]
AR035768A1 (es) Compuesto derivado de bencimidazol y su uso en la fabricacion de un medicamento
AR012310A1 (es) Composicion de 4-[pirazol-1-il]-benceno-sulfonamida inhibidora de la ciclooxigenasa-2 util en el tratamiento y la prevencion de la demencia y su usopara preparar un medicamento para tratar ese mal.
IT1307330B1 (it) Derivati chinolinici

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure